Picture of Piramal Pharma (Mumbai) logo

PPLPHARMA Piramal Pharma (Mumbai) News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Piramal Pharma Limited Announces Consolidated Results For Q2 And H1 FY2024

Oct 28 (Reuters) - Piramal Pharma Ltd  PIRM.NS :
    * Q2 FY24 REVENUE FROM OPERATION INR 1,911 CRORES, UP 11%
    * LIMITED ANNOUNCES CONSOLIDATED RESULTS FOR Q2 AND H1
FY2024

Source text for Eikon:  ID:nCNW7b99Ra 
Further company coverage:  PIRM.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Piramal Pharma (Mumbai)

See all news